Skip to main content
. Author manuscript; available in PMC: 2009 Aug 17.
Published in final edited form as: Surg Gynecol Obstet. 1979 Dec;149(6):815–821.

TABLE II. STEPS IN MANAGEMENT.

  • STEP 1.Accurate assessment of antibodies against screening panel Possibilities are:

    1. Antibody-free

    2. Antibodies present*

      1. Anti-T, warm … worst

      2. Anti-B, warm … bad

      3. Anti-B, cold … good?

  • STEP 2. Time or thoracic duct drainage pretreatment leading to transplantation from a cross match negative donor

    1. Patient antibody-free or with cold antibodies … 21 days

    2. Patient with warm anti-T or warm anti-B antibodies … ≥35 days

  • STEP 2 (alternative). Time or thoracic duet drainage pretreatment leading to transplantation from a cross match positive donor

    1. Patient with warm anti-B antibodies … ≥35 days

    2. Delay transplantation in patients with warm anti-T antibodies until titer is below 1:4

*

Warm antibodies are IgG. Cold antibodies are IgM.